Tavistock Investments PLC Correction to no. of shares admitted to trading (8212Y)

TIDMTAVI

RNS Number : 8212Y

Tavistock Investments PLC

14 September 2020

14 September 2020

Tavistock Investments Plc

Correction to number of shares admitted to trading on AIM

Tavistock Investment Plc ("Tavistock" or the "Company") has identified that, due to an administrative error in 2015, the number of ordinary shares of 1p each in the Company ("Ordinary Shares") that are in issue does not match the number of Ordinary Shares for which applications have been made for admission to trading on AIM. The Company has therefore applied for 1,733,030 Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective on or around 18 September 2020. The 1,733,030 Ordinary Shares that were omitted from admission to trading on AIM represent approximately 0.29% of the issued share capital of the Company.

The Company's issued share capital consists of 607,795,801 Ordinary Shares and following the Admission of the 1,733,030 Ordinary Shares to trading on AIM this figure will remain unchanged from the Company's last announcement regarding its total voting rights figure which was made on 19 March 2020. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 607,795,801 . Following Admission, the number of Ordinary Shares admitted to trading on AIM will also be 607,795,801 .

For further information

 
 Tavistock Investments Plc                    Tel: [phone] 
  Oliver Cooke 
  Brian Raven 
 
 Allenby Capital Limited (Nominated adviser   Tel: [phone] 
  and broker) 
  Nick Naylor/ Nick Athanas/Liz Kirchner 
  (Corporate Finance) 
  Tony Quirke (Sales) 
 
 Vested                                       Tel: [phone] 
  Sophie Paterson 
  Elspeth Rothwell 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDZGMLNFNGGZM

(END) Dow Jones Newswires

September 14, 2020 02:00 ET (06:00 GMT)